Answers are grounded in this paper and cite their sources.
Case report demonstrates moyamoya disease developing during thalidomide therapy for leprosy reaction, highlighting potential cerebrovascular risks.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: